tiprankstipranks
Verastem Outlines Strategic Priorities for 2024
Company Announcements

Verastem Outlines Strategic Priorities for 2024

Verastem (VSTM) has released an update to notify the public and investors about a regulation fd disclosure.

Verastem, Inc. announced its strategic priorities and forthcoming catalysts for the year 2024 in a press release dated January 29, 2024.

For further insights into VSTM stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyVerastem doses first patient in GFH375/VS-7375 trial
TheFlyVerastem price target lowered to $18 from $34 at Truist
TheFlyVerastem to be added to the Russell 3000 & Microcap Indexes effective July 1
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!